Skip to content
Screener

NovoCure NVCR Japan — Net revenues

Other geography segments

United States
$102.96M
Germany
$23.34M
France
$21.35M
Greater China
$5.96M

Similar metrics at other companies

Albany International Inc. logo
AINBrazil — Net revenues
$17.16M+2.5%
Albany International Inc. logo
AINChina — Net revenues
$15.58M-8.0%
Albany International Inc. logo
AINFrance — Net revenues
$19.09M-5.9%
Albany International Inc. logo
AINMexico — Net revenues
$14.6M+0.8%
Albany International Inc. logo
AINSwitzerland — Net revenues
$27.69M+0.9%
Mercury Systems logo
MRCYU.S. — Net revenues
$229.43M+14.6%

Other financials

Income statement

See full
Revenue$183.6M+15.6%
Gross profit$142.5M+21.4%
Operating income-$10.6M+73.3%
Net income-$15.7M+61.0%
EPS (diluted)-$0.13+63.9%

Balance sheet

See full
Cash & equivalents$93.7M-37.4%
Total debt$37.5M-12.4%
Total equity$338.1M-3.2%
Total assets$795.2M-36.2%

Cash flow

See full
Operating cash flow$8.1M+151%
CapEx$6.9M+26.1%
Free cash flow$1.2M+106%

Valuation

See full
Market cap$1.91B+56.6%
Enterprise value$1.85B+66.6%
P/S2.7×+0.8×

Profitability

See full
Gross margin76.1%-0.3pp
Operating margin-22.1%-3.6pp
Net margin-21.2%-3.8pp
FCF margin-3.6%-1.5pp

Returns & leverage

See full
Return on equity-43.2%-4.0pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: NovoCure’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001645113-26-000062
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025Year ended Year ended December 31, 2025
International markets:
Germany23,34119,07447,84537,79279,407
France21,34718,41644,22536,27576,189
Japan11,7809,48422,02318,19337,786
Other international markets18,20512,97933,88424,91656,898
International markets - Total74,67359,953147,977117,176250,280
Greater China (1)5,9564,59110,7519,20819,441
Total net revenues$183,584$158,805$357,639$313,799$655,353

Item 1. Financial Statements

FAQ

What is NovoCure's japan — net revenues?
NovoCure (NVCR) reported japan — net revenues of $11.78M in Q2 2026.
How has NovoCure's japan — net revenues changed year-over-year?
NovoCure's japan — net revenues increased by 24.2% year-over-year, from $9.48M to $11.78M.
What is the long-term trend for NovoCure's japan — net revenues?
Over 4 years (2021 to 2025), NovoCure's japan — net revenues has grown at a 2.2% compound annual growth rate (CAGR), from $34.64M to $37.79M.
What does japan — net revenues mean?
This metric represents the total gross sales generated from the sale of medical devices and related services within the Japanese geographic market, net of returns and allowances. It serves as a key indicator of the company's commercial penetration and market adoption of its oncology treatment technologies in this specific region. Tracking this revenue stream helps investors assess the company's international growth strategy and the effectiveness of its local distribution and regulatory efforts.

Ask your AI about NovoCure's japan — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude